Company intelligence / Profile preview

Adamo Bioscience

Ownership: Private
Development stage: Commercial

Overview

The company’s flagship product, the "Adamo Method," has shown strong results in a clinical study with up to 86% of participants reporting improved sexual satisfaction. Other improvements included better communication, increased arousal/lubrication/orgasm quality/frequency among women, and greater feelings of love between partners. Results are pending peer review.

Therapeutic areas: Men's HealthPsychiatryWomen's Health
Modalities: Digital therapeutic programPsychedelic compoundsTechnology solutions for sexual health and intimacy
Industry: Biotech

Beyond the preview

Go deeper on Adamo Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adamo Bioscience.

Explore the full profile